Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2011

01.01.2011 | Original Article

Peripheral Arthritis in the Course of Inflammatory Bowel Diseases

verfasst von: İlhami Yüksel, Hilmi Ataseven, Ömer Başar, Seyfettin Köklü, İbrahim Ertuğrul, Aysel Ülker, Ülkü Dağlı, Nurgül Şaşmaz

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Musculoskeletal disorders are well-defined extra-intestinal manifestations of inflammatory bowel diseases (IBD). There is little data regarding the frequencies of IBD and extra-intestinal manifestations from Central and East Europe and Middle Eastern countries.

Aims

To determine the prevalence of peripheral arthritis in IBD and to document the relationship to other extra-intestinal manifestations.

Methods

Enrolled in the study were 357 patients who were diagnosed with IBD from December 2002 through January 2008. All of the patients underwent a detailed whole-body examination by a gastroenterologist and rheumatologist.

Results

IBD-related peripheral arthritis (IBDPA) was found in 66 (18.5%) of the 357 patients (28.3% Crohn’s disease, 13.5% ulcerative colitis; p = 0.001 χ = 11.62). IBDPA was more frequent in female patients (60.6 vs. 39.4%, p = 0.000, χ = 11.12). In eight (12.1%) cases, IBDPA occurred before the onset of IBD. Acute self-limiting episodes, recurrences of the attacks, and persistent symptoms of arthritis were present in 40 (60.6%), 26 (39.3%), and 29 (45.7%) patients, respectively. Arthritis was symmetrical in 33 (50%) cases. Knees (65.2%) and ankles (62.1%) were the most commonly affected joints. Erythema nodosum and pyoderma gangrenosum were more common among patients with IBDPA than patients without it (p = 0.001, χ = 10.49, and p = 0.000 χ = 25.77, respectively).

Conclusions

IBDPA is a frequent extra-intestinal complication of IBD. Those of female gender and the presence of Crohn’s disease, erythema nodosum and pyoderma gangrenosum have a higher risk to develop IBDPA.
Literatur
1.
Zurück zum Zitat Salvarani C, Fornaciari G, Beltrami M, Macchioni PL. Musculoskeletal manifestations in inflammatory bowel disease. Eur J Intern Med. 2000;11:210–214.CrossRefPubMed Salvarani C, Fornaciari G, Beltrami M, Macchioni PL. Musculoskeletal manifestations in inflammatory bowel disease. Eur J Intern Med. 2000;11:210–214.CrossRefPubMed
2.
Zurück zum Zitat Gran JT, Husby G. Joint manifestations in gastrointestinal diseases. 1. Pathophysiological aspects, ulcerative colitis and Crohn’s disease. Dig Dis. 1992;10:274–294.CrossRefPubMed Gran JT, Husby G. Joint manifestations in gastrointestinal diseases. 1. Pathophysiological aspects, ulcerative colitis and Crohn’s disease. Dig Dis. 1992;10:274–294.CrossRefPubMed
3.
Zurück zum Zitat Turkcapar N, Toruner M, Soykan I, et al. The prevalence of extra-intestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int. 2006;2:663–668.CrossRef Turkcapar N, Toruner M, Soykan I, et al. The prevalence of extra-intestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int. 2006;2:663–668.CrossRef
4.
Zurück zum Zitat Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998;42:387–391.CrossRefPubMed Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998;42:387–391.CrossRefPubMed
5.
Zurück zum Zitat Salvarani C, Vlachonikolis IG. van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M, Olivieri I, Di Gennaro F, Politi P, Stockbrugger RW, Russel MG; European Collaborative IBD Study Group. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol. 2001;36:1307–1313.CrossRefPubMed Salvarani C, Vlachonikolis IG. van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M, Olivieri I, Di Gennaro F, Politi P, Stockbrugger RW, Russel MG; European Collaborative IBD Study Group. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol. 2001;36:1307–1313.CrossRefPubMed
6.
Zurück zum Zitat Palm O, Moum B, Jahnsen J, Gran JT. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology (Oxford). 2001;40:1256–1261.CrossRef Palm O, Moum B, Jahnsen J, Gran JT. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology (Oxford). 2001;40:1256–1261.CrossRef
7.
Zurück zum Zitat De Vos M, De Keyser F, Mielants H, Cuvelier C, Veys E. Review article: bone and joint diseases in inflammatory bowel disease. Aliment Pharmacol Ther. 1998;12:397–404.CrossRefPubMed De Vos M, De Keyser F, Mielants H, Cuvelier C, Veys E. Review article: bone and joint diseases in inflammatory bowel disease. Aliment Pharmacol Ther. 1998;12:397–404.CrossRefPubMed
8.
Zurück zum Zitat Mielants H, Veys EM, Goethals K, Van Der Straeten C, Ackerman C. Destructive lesions of small joints in seronegative spondyloarthropathies relation to gut inflammation. Clin Exp Rheumatol. 1990;8:23–27.PubMed Mielants H, Veys EM, Goethals K, Van Der Straeten C, Ackerman C. Destructive lesions of small joints in seronegative spondyloarthropathies relation to gut inflammation. Clin Exp Rheumatol. 1990;8:23–27.PubMed
9.
Zurück zum Zitat Tozun N, Atug O, Imeryuz N, et al. Yurdaydin C; Members of the Turkish IBD Study Group. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey. J Clin Gastroenterol. 2009;43:51–57.CrossRefPubMed Tozun N, Atug O, Imeryuz N, et al. Yurdaydin C; Members of the Turkish IBD Study Group. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey. J Clin Gastroenterol. 2009;43:51–57.CrossRefPubMed
10.
Zurück zum Zitat Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996;23:29–34.CrossRefPubMed Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996;23:29–34.CrossRefPubMed
11.
Zurück zum Zitat Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine. 1976;55:401–412.CrossRefPubMed Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine. 1976;55:401–412.CrossRefPubMed
12.
Zurück zum Zitat Calin A, Fries JF. An “experimental” epidemic of Reiter’s syndrome revisited. Ann Intern Med. 1976;84:564–566.PubMed Calin A, Fries JF. An “experimental” epidemic of Reiter’s syndrome revisited. Ann Intern Med. 1976;84:564–566.PubMed
13.
Zurück zum Zitat Schorr-Lesnick B, Brandt LJ. Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol. 1988;83:216–223.PubMed Schorr-Lesnick B, Brandt LJ. Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol. 1988;83:216–223.PubMed
14.
15.
Zurück zum Zitat Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National cooperative Crohn’s disease study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77:914–920.PubMed Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National cooperative Crohn’s disease study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77:914–920.PubMed
16.
Zurück zum Zitat Haslock I, Wright V. The musculo-squeletal complications of Crohn’s disease. Medicine. 1973;52:217–225.CrossRefPubMed Haslock I, Wright V. The musculo-squeletal complications of Crohn’s disease. Medicine. 1973;52:217–225.CrossRefPubMed
17.
Zurück zum Zitat Yüksel I, Başar O, Ataseven H, et al. Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:546–550.CrossRefPubMed Yüksel I, Başar O, Ataseven H, et al. Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:546–550.CrossRefPubMed
Metadaten
Titel
Peripheral Arthritis in the Course of Inflammatory Bowel Diseases
verfasst von
İlhami Yüksel
Hilmi Ataseven
Ömer Başar
Seyfettin Köklü
İbrahim Ertuğrul
Aysel Ülker
Ülkü Dağlı
Nurgül Şaşmaz
Publikationsdatum
01.01.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1260-z

Weitere Artikel der Ausgabe 1/2011

Digestive Diseases and Sciences 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.